PT-141 (Libido/Sex drive) 10mg - Apoxar

PT-141

PT-141 PROFILE

PT-141, or Bremelanotide, is a peptide hormone used for enhancing erection function and increasing libido. It is derived from Melanotan II (MT2), which is known for promoting tanning, enhanced performance, sexual desire, and satisfaction. Unlike drugs like Viagra, Bremelanotide not only affects the vessels of sex organs but also increases sex drive in both men and women.

BENEFITS OF PT-141

The thing that makes PT-141 so beneficial for both men and women is that it affects the central nervous system (CNS) arousing mental desire for sexual activity. While PED5’s all work on erections when the problem is caused by blood flow issues, this peptide affects libido increasing sexual desire and sexual satisfaction.

Erectile dysfunction (ED) can also be caused by low testosterone levels, and that’s when the administration of testosterone will help. However, if ED is not connected with poor blood circulation, many will try out PT-141 since the problem can be related to CNS.

So the effects of Bremelanotide are all sexually related. You’ll see a great increase in libido, which means improved sexual drive, sensitivity, and satisfaction. Besides, it can have a positive impact on erectile dysfunction if it’s not the result of blood flow issues.

HOW TO TAKE PT-141

The peptide is administrated by subcutaneous (less often intramuscular) injections. The half-life of the drug is 2-4 hours, so it’s recommended to inject it 45 min before sexual activity.

The dosage varies from 0.5mg to 2mg per dose depending on the weight of a user. Women should inject half of a male dosage (0.25-1mg). It’s not advised to use PT-141 more than eight times per month, and only once per 24 hours.

Bremelanotide is sometimes used as a part of erectile dysfunction treatment with PED5’s, or testosterone replacement therapy.

PT-141 POSSIBLE SIDE EFFECTS

There are a few side effects of PT-141, but they are all rather mild. The most common ones are nausea (40% of users) and vomiting, especially after the first use. Taking anti-nausea medication before the injection may help prevent the issue.

Other side effects include headache, dizziness, flushing, and high blood pressure in very few cases. Some individuals also experience irritation at injection sites and have to rotate them constantly to prevent bruising or soreness.

POPULAR QUESTIONS AND ANSWERS ABOUT PT-141

Does PT 141 really work?

PT-141 works effectively as a treatment for low libido in men and women, and erectile dysfunction solution. In the USA, it was approved for medical use in 2019, which proves its effectiveness once again.

However, Bremelanotide does not improve erections through the vascular system, as Viagra or Cialis do, but directly affects your nervous system, which helps achieve enhanced desire and satisfaction from sexual activity. This makes it a safer drug for users with cardiovascular problems.

How should you take Bremelanotide?

The injections have to be done subcutaneously or rarely intramuscularly, depending on a user’s preference. The drug is administrated 45 minutes before sexual activity at 0.5mg-2mg per shot. Do not inject the drug more often than every 24 hours with a maximum of 8 injections per month.

Can you take PT 141 orally?

Oral administration is not possible with this peptide because it just won’t be working properly this way. It won’t affect the CNS but will quickly decay in the gastrointestinal tract.

How long does it take for PT 141 to kick in?

The rate of response depends on your individual traits. Healthy users usually respond to the peptide in several minutes, and the effect can last up to 3-4 hours, in some rare cases even to 72 hours. For people with erectile dysfunction, it takes longer to see the effects, about 2-3 hours.

PT-141 REVIEWS

PT-141 is a unique drug because of its neurological abilities and positive impact on male and, more surprisingly, female libido, which is often neglected. It is successfully used to increase sexual desire and satisfaction with minimal side effects and little risk of cardiovascular issues.